IRON Disc Medicine, Inc.

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business: clinical-stage biopharma developing novel treatments targeting red blood cell biology, focusing on heme biosynthesis and iron homeostasis pathways
• • New emphasis: submission of NDA for bitopertin in erythropoietic porphyrias (EPP and XLP) with FDA accelerated approval pursuit, ongoing Phase 3 APOLLO trial initiated May 2025

Risk Factors

• • Regulatory risk: Dependency on FDA approval timing and conditions for product candidates impacts commercialization and cost structure
• • Macroeconomic threat: Cash runway extends only to 2029 with $791.2M liquidity; accelerated spending could exhaust funds earlier

Management Discussion & Analysis

• • No revenue generated; net loss $212.2M in 2025 vs $109.4M in 2024, loss doubled YoY
• • Operating expenses up $106.3M YoY: R&D $170.6M vs $96.7M, SG&A $65.4M vs $33.0M

Management Discussion & Analysis

• • No quarterly revenue or YoY change data disclosed in provided section
• • No profitability or margin figures presented in provided text

Risk Factors

• • New risk: Rapid NDA filing for bitopertin in EPP and XLP in Sept 2025 with FDA's National Priority Voucher accelerates review to 1-2 months, increasing near-term regulatory pressure
• • Updated financial risk: Entered $200M senior secured Hercules Loan in Nov 2024 with maturity Dec 2029, including restrictive covenants and minimum qualified cash requirements

What are the latest IRON SEC filings in 2026?

Disc Medicine, Inc. (IRON) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on February 27, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did IRON file its most recent 10-K annual report?

Disc Medicine, Inc. (IRON) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view IRON 10-Q quarterly reports?

Disc Medicine, Inc. (IRON)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every IRON 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has IRON filed recently?

Disc Medicine, Inc. (IRON)'s most recent 8-K was filed on February 27, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find IRON insider trading activity (Form 4)?

SignalX aggregates every IRON Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does IRON file with the SEC?

Disc Medicine, Inc. (IRON) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new IRON filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Disc Medicine, Inc. (IRON).

What is IRON's SEC CIK number?

Disc Medicine, Inc. (IRON)'s SEC CIK (Central Index Key) number is 1816736. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1816736 to look up all IRON filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find IRON return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Disc Medicine, Inc. (IRON) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.